Originally presented on September 11th, 2021 as a main session at the 2021 Virtual MDF Annual Conference.
Representatives from biotech and pharma companies will provide updates on their drug development efforts in the DM field. Day 2 features PepGen, NeuBase Therapeutics, ARTHEx biotech, and Expansion Therapeutics.
- Jane Larkindale, PhD, PepGen
- Beatriz Llamusi, PhD, ARTHEx biotech
- Dietrich A. Stephan, PhD, NeuBase Therapeutics
- Valerie Cullen, PhD, Expansion Therapeutics